Five of the world’s biggest drugs companies have agreed to slash the price of
their anti-HIV drugs in developing countries by 85 per cent following sustained
pressure from health agencies, Third World governments and patient groups
(51¶¯Âþ, 29 April, p 14).
One of the companies, Glaxo Wellcome, is
cutting the price of triple drug therapy from $16 to $2 a day. But
pressure groups have warned that even at these prices, poverty and a lack of
health infrastructure in poor countries will mean the benefits are limited.
To continue reading, today with our introductory offers
Advertisement
More from 51¶¯Âþ
Explore the latest news, articles and features
Health
The mysterious reason why women get hotter from age 18 to 42
51¶¯Âþ
Comment
This is the most underrated sci-fi film franchise of the 21st century
Culture
Comment
Shiver me timbers: Do we have to worry about space pirates now?
Regulars
Life
PMOS shows us why many scientific terms need to be renamed
Leader
Popular articles
Trending 51¶¯Âþ articles
1
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
2
Mystery of the ancient giant stone jars of Laos may have been solved
3
Photos reveal unexpected details from the world's first atomic test
4
The distant world that is our best hope of finding alien life
5
Can we harness quantum effects to create a new kind of healthcare?
6
SpaceX is about to launch tallest and most powerful rocket in history
7
After news about Oliver Sacks's "lies", we revisit his best-loved book
8
PMOS shows us why many scientific terms need to be renamed
9
We may finally know why dinosaurs like T. rex evolved tiny arms
10
Rebooting stem cells builds aged muscles and assists injury recovery
